 |
PDBsum entry 1fn4
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
1fn4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
Crystal structure of fab198, an efficient protector of acetylcholine receptor against myasthenogenic antibodies
|
|
Structure:
|
 |
Monoclonal antibody against acetylcholine receptor. Chain: a, c. Monoclonal antibody against acetylcholine receptor. Chain: b, d
|
|
Source:
|
 |
Rattus norvegicus. Norway rat. Organism_taxid: 10116. Organism_taxid: 10116
|
|
Biol. unit:
|
 |
Dimer (from
)
|
|
Resolution:
|
 |
|
2.80Å
|
R-factor:
|
0.198
|
R-free:
|
0.294
|
|
|
Authors:
|
 |
K.Poulas,E.Eliopoulos,E.Vatzaki,J.Navaza,M.Kontou
|
Key ref:
|
 |
K.Poulas
et al.
(2001).
Crystal structure of Fab198, an efficient protector of the acetylcholine receptor against myasthenogenic antibodies.
Eur J Biochem,
268,
3685-3693.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
21-Aug-00
|
Release date:
|
26-Sep-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Eur J Biochem
268:3685-3693
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of Fab198, an efficient protector of the acetylcholine receptor against myasthenogenic antibodies.
|
|
K.Poulas,
E.Eliopoulos,
E.Vatzaki,
J.Navaza,
M.Kontou,
N.Oikonomakos,
K.R.Acharya,
S.J.Tzartos.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structure of the Fab fragment of the rat monoclonal antibody 198,
with protective activity for the main immunogenic region of the human muscle
acetylcholine receptor against the destructive action of myasthenic antibodies,
has been determined and refined to 2.8 A resolution by X-ray crystallographic
methods. The mouse anti-lysozyme Fab D1.3 was used as a search model in
molecular replacement with the AMORE software. The complementarity determining
regions (CDR)-L2, CDR-H1 and CDR-H2 belong to canonical groups. Loops CDR-L3,
CDR-H2 and CDR-H3, which seem to make a major contribution to binding, were
analyzed and residues of potential importance for antigen-binding are examined.
The antigen-binding site was found to be a long crescent-shaped crevice. The
structure should serve as a model in the rational design of very high affinity
humanized mutants of Fab198, appropriate for therapeutic approaches in the model
autoimmune disease myasthenia gravis.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Ribbon representation of the Fab198 molecule. The
molecule exhibits the typical immunoglobulin fold. The CDRs are
shown in bold. (A) The molecule is shown with the variable
chains (V[L]–V[H]) at the top and the constant (C[L]–C[H])
at the bottom. (B) View from the top of the molecule showing the
access to the binding crevice (as in Fig. 5 Go- ). The
figure was prepared with MOLSCRIPT [41].
|
 |
Figure 5.
Fig. 5. Top view of the antigen-binding site of the Fab198
molecule in stereo. The binding crevice is formed by residues of
V[H] (in red) and V[L] (in blue). The important interacting
residues are labeled in their respective colours. Black lines
represent the Ca trace of VH and VL. CDRs (Ca atoms only) are
represented by thick black lines and labeled (L1-L3, H1-H3).
This view corresponds to Fig. 1B Go- and Fig.
6B Go- . The
drawing was prepared with MOLSCRIPT [41].
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the Federation of European Biochemical Societies:
Eur J Biochem
(2001,
268,
3685-3693)
copyright 2001.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Zouridakis,
P.Zisimopoulou,
K.Poulas,
and
S.J.Tzartos
(2009).
Recent advances in understanding the structure of nicotinic acetylcholine receptors.
|
| |
IUBMB Life,
61,
407-423.
|
 |
|
|
|
|
 |
J.Lindstrom,
J.Luo,
and
A.Kuryatov
(2008).
Myasthenia gravis and the tops and bottoms of AChRs: antigenic structure of the MIR and specific immunosuppression of EAMG using AChR cytoplasmic domains.
|
| |
Ann N Y Acad Sci,
1132,
29-41.
|
 |
|
|
|
|
 |
J.M.Lindstrom
(2003).
Nicotinic acetylcholine receptors of muscles and nerves: comparison of their structures, functional roles, and vulnerability to pathology.
|
| |
Ann N Y Acad Sci,
998,
41-52.
|
 |
|
|
|
|
 |
T.K.Sixma,
and
A.B.Smit
(2003).
Acetylcholine binding protein (AChBP): a secreted glial protein that provides a high-resolution model for the extracellular domain of pentameric ligand-gated ion channels.
|
| |
Annu Rev Biophys Biomol Struct,
32,
311-334.
|
 |
|
|
|
|
 |
J.Lindstrom
(2002).
Autoimmune diseases involving nicotinic receptors.
|
| |
J Neurobiol,
53,
656-665.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |
|